|
|
Volumn 848, Issue 2, 2007, Pages 379-383
|
|
The quantification of erlotinib (OSI-774) and OSI-420 in human plasma by liquid chromatography-tandem mass spectrometry
|
|
Author keywords
Erlotinib; HPLC MS MS; OSI 774
|
|
Indexed keywords
ERLOTINIB;
ETHYL ACETATE;
MIDAZOLAM;
OSI-774;
BODY FLUIDS;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
MASS SPECTROMETRY;
METABOLITES;
TUMORS;
DRUG PRODUCTS;
ACETIC ACID ETHYL ESTER;
DOCETAXEL;
DRUG METABOLITE;
ERLOTINIB;
HEXANE;
MIDAZOLAM;
OSI 420;
UNCLASSIFIED DRUG;
ACCURACY;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CLINICAL ARTICLE;
DEVICE;
DRUG BLOOD LEVEL;
DRUG STRUCTURE;
ELECTROSPRAY;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN;
LIQUID LIQUID EXTRACTION;
LUNG NON SMALL CELL CANCER;
PRIORITY JOURNAL;
QUANTITATIVE ANALYSIS;
QUANTITATIVE ASSAY;
STANDARDIZATION;
TANDEM MASS SPECTROMETRY;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
DRUG STABILITY;
HUMANS;
MOLECULAR STRUCTURE;
QUINAZOLINES;
REPRODUCIBILITY OF RESULTS;
SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;
TANDEM MASS SPECTROMETRY;
|
|
EID: 33947541184
PISSN: 15700232
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jchromb.2006.10.046 Document Type: Article |
|
Times cited : (45)
|
|
References (6)
|
